A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
quick grab on fda fears
What do you think of the RXII Dividend (Spin off)? 1st day of trading today and it was up BIG. Hold it? Sell it? Sell and buy back later? CYTR kept 49% of RXII yet CYTR trades down...I can understand down some but if they own 49% of RXII why such a large hair cut? thanks Puckhaug
i had bought more cytr because rxii was coming... wish it had hit my account on day 1 or i would have sold at 18+... my guess is that is why it got that high (illiquidity)... The CYTR haircut was probably an indication that they mispriced RXII at $5 (if you look at the two market caps together, they are similar to what it was before - ie the market thinks cytr value is rxii). I'm not that hot on CYTR right now - i'd look at ABPI, PANC, DDSS, ADLS.Best of luck to you.